Schedule 13G ownership disclosure

LENZ THERAPEUTICS INC

Security class unavailable · CUSIP: 52635N103

Event date: 2024-07-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-083538
Form type
SC 13G
Filer
LENZ Therapeutics, Inc.
CIK
CIK 1815776
Filed
Jul 29, 2024
Reporting period
Jul 17, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub